Ramachandran Murali
VP of Research and Development · Kairos Pharma, LTD.
- 2024
- Nov 26, 2025
- 2
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Ramachandran Murali. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John S. Yu - $6K in KAPA purchases and sales on record
- Doug Samuelson - $4K in KAPA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ramachandran Murali?
Ramachandran Murali is a corporate insider, tracked as VP of Research and Development of Kairos Pharma, LTD. (KAPA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ramachandran Murali last file a Form 4?
The most recent primary Form 4 on record is dated 26 November 2025, one of 2 filings going back to 2024.
Has Ramachandran Murali been buying or selling stock?
Recorded transactions: 1 open-market purchase ($318) and 0 open-market sales across all tracked filings.
